Brigatinib Plus Chemotherapy or Local Consolidation Therapy in ALK Positive Advanced Non-small Cell Lung Cancer (BrightStar-2)
Clinical trial NCT06522360 · WITHDRAWN
Trial details
- NCT number
- NCT06522360
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-11
- Primary completion
- 2025-04-17
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.